リーシュマニア症治療の世界市場（～2026年）

• 英文タイトル：Global Leishmaniasis Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12497
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はリーシュマニア症治療のグローバル市場について調査・分析したレポートです。種類別（アンチモン酸メグルミン、ペンタミジン、ヒドロキシアミジンスチルベン、アムホテリシンB）市場規模、用途別（内臓リーシュマニア症、皮膚リーシュマニア症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別リーシュマニア症治療の競争状況、市場シェア
・世界のリーシュマニア症治療市場：種類別市場規模 2015年-2020年（アンチモン酸メグルミン、ペンタミジン、ヒドロキシアミジンスチルベン、アムホテリシンB）
・世界のリーシュマニア症治療市場：種類別市場規模予測 2021年-2026年（アンチモン酸メグルミン、ペンタミジン、ヒドロキシアミジンスチルベン、アムホテリシンB）
・世界のリーシュマニア症治療市場：用途別市場規模 2015年-2020年（内臓リーシュマニア症、皮膚リーシュマニア症）
・世界のリーシュマニア症治療市場：用途別市場規模予測 2021年-2026年（内臓リーシュマニア症、皮膚リーシュマニア症）
・北米のリーシュマニア症治療市場分析：米国、カナダ
・ヨーロッパのリーシュマニア症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのリーシュマニア症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のリーシュマニア症治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのリーシュマニア症治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Merck、iCo Therapeutics、AEterna Zentaris、AEterna Zentaris AG、Eurofins Advinus、Pieris Pharmaceuticals、Dafra Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

A drug used to treat diseases caused by parasitic protozoa leishmania

Market Analysis and Insights: Global Leishmaniasis Treatment Market
The global Leishmaniasis Treatment market size is projected to reach US$ 131.3 million by 2026, from US$ 98.1 million in 2020, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leishmaniasis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leishmaniasis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leishmaniasis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leishmaniasis Treatment market.

Global Leishmaniasis Treatment Scope and Market Size
Leishmaniasis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leishmaniasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Meglumine Antimoniate
Pentamidine
Hydroxyl Amidine Stilbene
Amphotericin B

Market segment by Application, split into
Visceral Leishmaniasis
Cutaneous Leishmaniasis

Based on regional and country-level analysis, the Leishmaniasis Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Leishmaniasis Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Merck
iCo Therapeutics
AEterna Zentaris
AEterna Zentaris AG
Eurofins Advinus
Pieris Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Meglumine Antimoniate
1.2.3 Pentamidine
1.2.4 Hydroxyl Amidine Stilbene
1.2.5 Amphotericin B
1.3 Market by Application
1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2026
1.3.2 Visceral Leishmaniasis
1.3.3 Cutaneous Leishmaniasis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leishmaniasis Treatment Market Perspective (2015-2026)
2.2 Global Leishmaniasis Treatment Growth Trends by Regions
2.2.1 Leishmaniasis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Leishmaniasis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Leishmaniasis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leishmaniasis Treatment Players by Market Size
3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2015-2020)
3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
3.4 Global Leishmaniasis Treatment Market Concentration Ratio
3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2019
3.5 Key Players Leishmaniasis Treatment Area Served
3.6 Key Players Leishmaniasis Treatment Product Solution and Service
3.7 Date of Enter into Leishmaniasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leishmaniasis Treatment Breakdown Data by Type (2015-2026)
4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2021-2026)

5 Leishmaniasis Treatment Breakdown Data by Application (2015-2026)
5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2015-2020)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Leishmaniasis Treatment Market Size (2015-2026)
6.2 North America Leishmaniasis Treatment Market Size by Type (2015-2020)
6.3 North America Leishmaniasis Treatment Market Size by Application (2015-2020)
6.4 North America Leishmaniasis Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Leishmaniasis Treatment Market Size (2015-2026)
7.2 Europe Leishmaniasis Treatment Market Size by Type (2015-2020)
7.3 Europe Leishmaniasis Treatment Market Size by Application (2015-2020)
7.4 Europe Leishmaniasis Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Leishmaniasis Treatment Market Size (2015-2026)
8.2 China Leishmaniasis Treatment Market Size by Type (2015-2020)
8.3 China Leishmaniasis Treatment Market Size by Application (2015-2020)
8.4 China Leishmaniasis Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Leishmaniasis Treatment Market Size (2015-2026)
9.2 Japan Leishmaniasis Treatment Market Size by Type (2015-2020)
9.3 Japan Leishmaniasis Treatment Market Size by Application (2015-2020)
9.4 Japan Leishmaniasis Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Leishmaniasis Treatment Market Size (2015-2026)
10.2 Southeast Asia Leishmaniasis Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Leishmaniasis Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Leishmaniasis Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Leishmaniasis Treatment Introduction
11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2015-2020))
11.1.5 Merck Recent Development
11.2 iCo Therapeutics
11.2.1 iCo Therapeutics Company Details
11.2.2 iCo Therapeutics Business Overview
11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2015-2020)
11.2.5 iCo Therapeutics Recent Development
11.3 AEterna Zentaris
11.3.1 AEterna Zentaris Company Details
11.3.2 AEterna Zentaris Business Overview
11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2015-2020)
11.3.5 AEterna Zentaris Recent Development
11.4 AEterna Zentaris AG
11.4.1 AEterna Zentaris AG Company Details
11.4.2 AEterna Zentaris AG Business Overview
11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2015-2020)
11.4.5 AEterna Zentaris AG Recent Development
11.5 Eurofins Advinus
11.5.1 Eurofins Advinus Company Details
11.5.2 Eurofins Advinus Business Overview
11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2015-2020)
11.5.5 Eurofins Advinus Recent Development
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Details
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2015-2020)
11.6.5 Pieris Pharmaceuticals Recent Development
11.7 Dafra Pharma
11.7.1 Dafra Pharma Company Details
11.7.2 Dafra Pharma Business Overview
11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2015-2020)
11.7.5 Dafra Pharma Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Meglumine Antimoniate
Table 4. Key Players of Pentamidine
Table 5. Key Players of Hydroxyl Amidine Stilbene
Table 6. Key Players of Amphotericin B
Table 7. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Leishmaniasis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Leishmaniasis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Leishmaniasis Treatment Market Share by Regions (2015-2020)
Table 11. Global Leishmaniasis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Leishmaniasis Treatment Market Share by Regions (2021-2026)
Table 13. Leishmaniasis Treatment Market Market Trends
Table 14. Leishmaniasis Treatment Market Drivers
Table 15. Leishmaniasis Treatment Market Challenges
Table 16. Leishmaniasis Treatment Market Restraints
Table 17. Global Leishmaniasis Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Leishmaniasis Treatment Market Share by Players (2015-2020)
Table 19. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2019)
Table 20. Global Leishmaniasis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Leishmaniasis Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Leishmaniasis Treatment Market Size Share by Type (2015-2020)
Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Leishmaniasis Treatment Market Size Share by Application (2015-2020)
Table 28. Global Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Leishmaniasis Treatment Market Size Share by Application (2021-2026)
Table 30. North America Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 32. North America Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 34. North America Leishmaniasis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Leishmaniasis Treatment Market Share by Country (2015-2020)
Table 36. Europe Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 38. Europe Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 40. Europe Leishmaniasis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Leishmaniasis Treatment Market Share by Country (2015-2020)
Table 42. China Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 43. China Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 44. China Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 45. China Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 46. China Leishmaniasis Treatment Market Size by Region (US$ Million) (2015-2020)
Table 47. China Leishmaniasis Treatment Market Share by Region (2015-2020)
Table 48. Japan Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 50. Japan Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 52. Japan Leishmaniasis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Leishmaniasis Treatment Market Share by Country (2015-2020)
Table 54. Southeast Asia Leishmaniasis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Leishmaniasis Treatment Market Share by Type (2015-2020)
Table 56. Southeast Asia Leishmaniasis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Leishmaniasis Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Leishmaniasis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Leishmaniasis Treatment Market Share by Country (2015-2020)
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Product
Table 63. Merck Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 64. Merck Recent Development
Table 65. iCo Therapeutics Company Details
Table 66. iCo Therapeutics Business Overview
Table 67. iCo Therapeutics Product
Table 68. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 69. iCo Therapeutics Recent Development
Table 70. AEterna Zentaris Company Details
Table 71. AEterna Zentaris Business Overview
Table 72. AEterna Zentaris Product
Table 73. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 74. AEterna Zentaris Recent Development
Table 75. AEterna Zentaris AG Company Details
Table 76. AEterna Zentaris AG Business Overview
Table 77. AEterna Zentaris AG Product
Table 78. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 79. AEterna Zentaris AG Recent Development
Table 80. Eurofins Advinus Company Details
Table 81. Eurofins Advinus Business Overview
Table 82. Eurofins Advinus Product
Table 83. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 84. Eurofins Advinus Recent Development
Table 85. Pieris Pharmaceuticals Company Details
Table 86. Pieris Pharmaceuticals Business Overview
Table 87. Pieris Pharmaceuticals Product
Table 88. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 89. Pieris Pharmaceuticals Recent Development
Table 90. Dafra Pharma Company Details
Table 91. Dafra Pharma Business Overview
Table 92. Dafra Pharma Product
Table 93. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2015-2020) (US$ Million)
Table 94. Dafra Pharma Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Meglumine Antimoniate Features
Figure 3. Pentamidine Features
Figure 4. Hydroxyl Amidine Stilbene Features
Figure 5. Amphotericin B Features
Figure 6. Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Visceral Leishmaniasis Case Studies
Figure 8. Cutaneous Leishmaniasis Case Studies
Figure 9. Leishmaniasis Treatment Report Years Considered
Figure 10. Global Leishmaniasis Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Leishmaniasis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Leishmaniasis Treatment Market Share by Regions (2021-2026)
Figure 13. Global Leishmaniasis Treatment Market Share by Players in 2019
Figure 14. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2019
Figure 16. North America Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 44. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 45. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 46. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 47. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 48. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 49. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

以下、関連資料のご紹介

軟骨肉腫治療の世界市場（～2026年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11355 2020年11月25日 96Pages
当調査資料は軟骨肉腫治療のグローバル市場について調査・分析したレポートです。種類別（外科的治療、化学療法、放射線療法）市場規模、用途別（病院、専門クリニック、がん治療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

大腸がんの世界市場（～2026年）

Global Colorectal Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY11436 2020年11月25日 93Pages
当調査資料は大腸がんのグローバル市場について調査・分析したレポートです。種類別（肉眼検査、顕微鏡検査、免疫化学、病期分類、腫瘍発芽）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

がん悪液質の世界市場（～2026年）

Global Cancer Cachexia Market Size, Status and Forecast 2020-2026
MRC2-11QY11229 2020年11月25日 96Pages
当調査資料はがん悪液質のグローバル市場について調査・分析したレポートです。種類別（プロゲストゲン、コルチコステロイド、併用療法）市場規模、用途別（病院店、小売薬局店、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

マイトジェン活性化プロテインキナーゼ1の世界市場（～2026年）

Global Mitogen Activated Protein Kinase 1 Market Insights and Forecast to 2026
MRC2-11QY07811 2020年11月20日 110Pages
当調査資料はマイトジェン活性化プロテインキナーゼ1のグローバル市場について調査・分析したレポートです。種類別（CB-745、JRP-890、KO-947、LY-3214996、その他）市場規模、用途別（膵管腺癌、固形腫瘍、結腸癌、乳癌、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

成長ホルモン分泌促進物質受容体タイプ1の世界市場（～2026年）

Global Growth Hormone Secretagogue Receptor Type 1 Market Insights and Forecast to 2026
MRC2-11QY07000 2020年11月20日 114Pages
当調査資料は成長ホルモン分泌促進物質受容体タイプ1のグローバル市場について調査・分析したレポートです。種類別（AZP-531、EXT-400、HM-01、OXE-103、その他）市場規模、用途別（放射線毒性、化学療法効果、アルコール依存症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ド...

前立腺特異抗原の世界市場（～2026年）

Global Prostate Specific Antigen Market Insights and Forecast to 2026
MRC2-11QY14434 2020年11月30日 116Pages
当調査資料は前立腺特異抗原のグローバル市場について調査・分析したレポートです。種類別（G-115、INO-5150、ADXS-PSA、AEZS-120、その他）市場規模、用途別（前立腺がん、転移性ホルモン不応性前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

成長ホルモン薬の世界市場（～2026年）

Global Growth Hormone Drug Market Insights and Forecast to 2026
MRC2-11QY06999 2020年11月20日 111Pages
当調査資料は成長ホルモン薬のグローバル市場について調査・分析したレポートです。種類別（ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、ヌトロピン）市場規模、用途別（小売薬局、病院薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

オーロラキナーゼBの世界市場（～2026年）

Global Aurora Kinase B Market Insights and Forecast to 2026
MRC2-11QY02735 2020年11月20日 117Pages
当調査資料はオーロラキナーゼBのグローバル市場について調査・分析したレポートです。種類別（AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他）市場規模、用途別（未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他）市場規模、地域別（北米、米国...

癌性食欲不振-悪液質症候群治療薬の世界市場（～2026年）

Global Cancer Anorexia-Cachexia Syndrome Drug Market Insights and Forecast to 2026
MRC2-11QY03646 2020年11月20日 118Pages
当調査資料は癌性食欲不振-悪液質症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（NEO-1940、C-1889、DLN-101、Foxo1-nRNA、AVGN-7、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

軟骨無形成症治療の世界市場（～2026年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13545 2020年11月30日 95Pages
当調査資料は軟骨無形成症治療のグローバル市場について調査・分析したレポートです。種類別（RBM-007、TA-46、B-701、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

内臓痛の世界市場（～2026年） Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutt…
皮膚肥満細胞症の世界市場（～2026年） Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumul…
ヒストプラズマ症治療の世界市場（～2026年） Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains lar…
軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…
交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…